2011 :

  • M. Weyland, F. Manero, A. Paillard, D. Grée, G. Viault, D. Jarnet, P. Menei, P. Juin, I. Chourpa, J-P. Benoit, R. Grée, E. Garcion.

Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor H A14-1.
J. Control Release, 2011 Apr 10;151(1):74-82. IF 5,7

  • E.Munnier, S.Cohen-Jonathan, K.Hervé, C.Linassier, M.Soucé, P. Dubois. I.Chourpa.

Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles : effects on subcellular distribution and cytotoxicity.
J. Nanopart. Res. (2011) 13:959–971. IF 3,3

  • Y. Çirpanli, E. Allard, C. Passirani, E. Bilensoy, L. Lemaire, S. Çalis, J-P Benoit.

Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Int. J. Pharm. 2011. 403(1-2): 201-206. IF 3,8


2010 :

  • A. Paillard-Giteau, M.C. Venier-Julienne, O. Thomas, V.T. Tran, X. Garric, J. Coudane, S. Marchal, I. Chourpa, C.N. Montero-Menei, J.P. Benoît.

Effect of various additives and polymers on the lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
Eur. J. Pharm. Biopharm., 2010, 75 (2),128-136. IF 3,3

  • A. Shkilnyy, E. Munnier, K. Hervé, M. Soucé, R. Benoit, S. Cohen-Jonathan, P. Limelette, M.-L. Saboungi, P. Dubois, I. Chourpa.

Synthesis and Evaluation of Novel Biocompatible Super-paramagnetic Iron Oxide Nanoparticles as Magnetic Anticancer Drug Carrier and Fluorescence Active Label.
J. Phys. Chem. C, 2010, 114 (13), 5850–5858. IF 4,2


2009 :

  • A. Shkilnyy, M. Soucé, P. Dubois, F. Warmont, M.L. Saboungi, I. Chourpa.

Poly(ethylene glycol)-stabilized silver nanoparticles for bioanalytical applications of SERS spectroscopy.
The Analyst, 2009, 134, 1868–1872. IF 3,8

2008 :

  • K. Hervé, L. Douziech-Eyrolles, E. Munnier, S. Cohen-Jonathan, M. Soucé, H. Marchais, P. Limelette, F. Warmont, M.L. Saboungi, P. Dubois, I. Chourpa

The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications.
Nanotechnology 2008, 19(46): 465608 (7pp). IF 3,3

  • E. Munnier, S. Cohen-Jonathan, C. Linassier, L. Douziech-Eyrolles, H. Marchais, M. Soucé, K. Hervé, P. Dubois, I. Chourpa.

Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Int J Pharm 2008, 363(1-2): 170-176. IF 2,4

  • I. Chourpa, F.H. Lei, P. Dubois, M. Manfait, G.D. Sockalingum.

Intracellular applications of analytical SERS spectroscopy and multispectral imaging.
Chem. Soc. Rev., 2008, 37: 993 - 1000. IF 17,4

2007 :

  • L. Douziech-Eyrolles, H. Marchais, K. Hervé, E. Munnier, M. Soucé, C. Linassier, P. Dubois, I. Chourpa.

Nanovectors of anticancer agents based on superparamagnetic iron oxide nanoparticles.
Int. J. Nanomed, 2007, 2(4), 541-550. IF 1,6

  • E. Munnier, F. Tewes, S. Cohen-Jonathan, C. Linassier, L. Douziech-Eyrolles, H. Marchais, M. Soucé, K. Hervé, P. Dubois, I. Chourpa

On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study.
Chem Pharm Bull. 2007, 55(7), 1006-1010. IF 1,2

  • S. Vibet, K. Mahéo, J. Goré, P. Dubois, P. Bougnoux, I. Chourpa.

Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.
Drug Metab Dispos. 2007, 35(5), 822-828. IF 3,9

  • F. Tewes, E. Munnier, B. Antoon, L. Ngaboni Okassa, S. Cohen-Jonathan, H. Marchais, L. Douziech-Eyrolles, M. Soucé, P. Dubois, I. Chourpa.

Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.
Eur J Pharm Biopharm. 2007, 66(3), 488-492. IF 2,6

  • L.N. Okassa, H.Marchais, L.Douziech-Eyrolles, K. Hervé, S. Cohen-Jonathan, E. Munnier, M. Soucé, C. Linassier, P. Dubois, I. Chourpa.

Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
Eur J Pharm Biopharm. 2007; 67(1), 31-8. IF 2,6

2006 :

  • I. Chourpa, V. Ducel, J. Richard, P. Dubois, F. Boury.

Conformational modifications of α-gliadin and globulin proteins upon complex coacervates formation with gum arabic as studied by Raman microspectroscopy.
Biomacromolecules, 2006, 7, 2616-2623. IF 4,2

  • T.Imakubo, T.Shirahata, K.Hervé, L.Ouahab.

Supramolecular organic conductors based on diiodo-TTFs and spherical halide ion X– (X = Cl, Br).
J.Mater.Chem., 2006, 16, 162-173.

  • K.Hervé, O.Cador, S.Golhen, K.Costuas, J.F.Halet, T.Shirahata, T.Muto, T.Imakubo, A.Miyazaki, L.Ouahab.

Iodine substituted TTFs radical cation salts with [M(isoq)2(NCS)4]- anions M = CrIII, GaIII: role of I…S and S…S contacts on structural and magnetic properties.
Chem.Mater., 2006, 18, 790-797.

  • K.Hervé, S.X.Liu, O.Cador, S.Golhen, Y.Le Gal, A.Bousseksou, H.Stoeckli, S.Decurtins, L.Ouahab.

Synthesis of BEDT-TTF bipyridine organic donor and the first FeII coordination complex with a redox-active ligand.
Eur.J.Inorg.Chem., 2006, 3498.

2005 :

  • I. Chourpa, L. Douziech-Eyrolles, L. Ngaboni-Okassa, J.F. Fouquenet, S. Cohen-Jonathan, M. Soucé, H. Marchais, P. Dubois.

Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterised by confocal Raman microspectroscopy.
The Analyst, 2005, 130, 1395-1403. IF 3,6

  • L. Ngaboni Okassa, H. Marchais, L. Douziech-Eyrolles, S. Cohen-Jonathan, M. Soucé, P. Dubois, I. Chourpa.

Development and characterization of poly(d,l-lactide-co-glycolide) nanoparticles loaded with magnetite/maghemite nanoparticles.
Int J Pharm, 2005, 302, 187-196. IF 2,4